New Directions
Volume 1 | Issue 1

Article 5

11-1-1973

Sickle Cell Anemia: A Growing Interest in an Old
Malady
Editorial Staff

Follow this and additional works at: http://dh.howard.edu/newdirections
Recommended Citation
Staff, Editorial (1973) "Sickle Cell Anemia: A Growing Interest in an Old Malady," New Directions: Vol. 1: Iss. 1, Article 5.
Available at: http://dh.howard.edu/newdirections/vol1/iss1/5

This Article is brought to you for free and open access by Digital Howard @ Howard University. It has been accepted for inclusion in New Directions by
an authorized administrator of Digital Howard @ Howard University. For more information, please contact lopez.matthews@howard.edu.

Staff: Sickle Cell Anemia: A Growing Interest in an Old Malady

Published by Digital Howard @ Howard University, 1973

1

New Directions, Vol. 1 [1973], Iss. 1, Art. 5

ickleCellAnernia

http://dh.howard.edu/newdirections/vol1/iss1/5

A Growing Interest
In an Old Malady

After many decades of neglect, coupled
with indifference, by the Federal Govemment and private volunteer health organizations, sickle cell anemia-an inherited
blood disorder that medical scientists say
affl icts 1 out of every 500 Black Americans
- has become a cause celebre.
Pressure from Blacks in high positions
and increased awareness by the public
about the nature of this illness are among
the key factors responsible for this new
development.
This newly-found interest in an old
malady that was identified clinically 63
years ago-still with no effective cureemerged a few years ago. It became a national cause following President Richard
M. Nixon's February 1971 health message
to Congress when he called sickle cell
anemia a high priority target and asked
for $5 million in Federal expenditures to
fight the disease during fiscal 1972.
Congress subsequently increased the
request to $10 million. And the Secretary
of the Department of Health, Education,
and Welfare appointed 11 prominent individuals to serve on the Department's
Sickle Cell Disease Advisory Committee,
"to advise on objectives and priorities."
In his message, Mr. Nixon said sickle
cell anemia was second only to cancer
in the Govemment's program of national
health priorities. But about the same time,
the Govemment made a request to Congress for $1.6 billion for a three-year
program to fight cancer. Critics, most of
them Blacks, charged the Administration
with double standards in dealing with
problems of Blacks, and strong Iy asserted
that the money set aside to fight sickle
cell disease was not enough to wage an
effective nationwide campaign against
one of Black America's long-neglected
health problems.
Ironically, instead of making adequate
funds available to fight sickle cell, critics
said the Nixon Administration at one
point attempted to block a bill introduced
by Senator John V. Tunney (D-California),
to provide $142 million for a three-year
campaign against the disease.
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The Tunney bill passed the Senate
unanimously in December 1971 but was
later reduced to$105 million in the House.
It was signed by the President in May,
1972 as the National Sickle Cell Anemia
Control Act.
Although the Act authorized expenditures of $105 million in three years ($25
million for fiscal 1973 and the rest for
fiscal 1974 and 1975), whether the full
amount authorized by Congress would
actually be appropriated is another question. In view of the Administration's
budget-cutting attitude, the likelihood of
substantial reduction in sickle cell funds
cannot be precluded.
Black institutions like Howard University and other organizations engaged in
sickle cell research and education programs are expected to receive more
money when the Federal funds are made
available. What portion they will get is
unknown.
In the past two and three years, sickle
cell anemia has become a popular cause
for politicians, businessmen, entertainers
and fund raisers.
"Sickle Cell Anemia Month" was proclaimed twice in Washington, D. C, by
Mayor-Commissioner Walter E. Washington. Other cities have done similarly.
At least seven states and the District
of Columbia passed measures requiring
compulsory testing (for sickle cell trait) of
Black schoolchi Idren. But unexpected
opposition from doctors and community
leaders who feared that such laws could
hurt Blacks, has apparently caused the
mod ification of some of the 'hasti Iy
adopted measures. The controversial
District of Columbia measure, which
would have required the compulsory testing of all Black schoolchildren beginning
in September, has been modified. As a
result, the testing of schoolchildren in the
District will be done on voluntary basis.
Some months ago, Dr. James E. Bowman, director of laboratories at the University of Chicago and an outspoken
critic of laws requiring compulsory testing

before any sickling

occurs.

for sickle cell trait, questioned the legality
or morality of the District of Columbia
measure (now revised) and a similar one
in Virginia. He said, at a sickle cell
symposium in Washirigton, D. C., he was
against measures that would single out
Blacks for genetic screening and warned
that, if they went unchallenged, such
measures could be used in a manner that
is not in the best interest of Blacks in this
country. A number of the 400 delegates
attending the symposium agreed.
What is Sickle Cell Anemia?

Sickle cell anemia is an inherited blood
condition, which for the most part occurs
in a relatively benign carrier called sickle
cell trait.
Approximately 1 out of every 10 Black
Americans, or about 2.5 million of the
Black population in this country, carry
only the gene for the sickling trait, NOT
THE DISEASE.Medical experts estimate
the deadly form, the actual disease, attacks 1 out of every 500 Black babies
born in this country. The number of Black
persons suffering from the disease is
estimated at 50,000 nationwide.
Sickle cell disease is caused by a
genetically determined defect in hemoglobin, the respiratory pigment in red
blood cells. Because of this defect, the
oxygen supply throughout the body is
diminished and the abnormal hemoglobin
molecules stick to one another causing
the normally doughnut-shaped red blood
cells to sickle.
The sickling condition impairs the flow
of blood to vital organs, such as the
spleen, lung and the central nervous
system, resulting in some damage to the
organs.
Complications from the disease include
susceptibility to respiratory infections,
chronic anemia, recurrent symptoms of
pain, headaches, swollen bellies and
joints; and under extreme conditions,
blindness, leg ulcers, crippling paralysis
and convulsions.
The victims experience painful attacks
several times a year. Medical experts call

Published by Digital Howard @ Howard University, 1973

3

New Directions, Vol. 1 [1973], Iss. 1, Art. 5
Sickle-Shaped
Red Blood Cells, abnormal cells,
such as those seen in the photo below, not only give
sickle cell disease its name but are also responsible
for the crippling and lethal effects of this inherited
blood disease.

the recurring painful episodes "crises."
Because of the recurrent attacks, children suffering from the disease are
usually bedridden several days, sometimes weeks, during a school year. Frequent absence from class causes some
children to lag in their studies. Also,
young victims of the disease can not
participate in most strenuous physical
activities enjoyed by their healthy peers,
This condition of limited childhood activity creates psychological problems
that, in most instances, require expert
counseling.
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Adult victims suffer similarly, but to a
lesser degree because they learn to cope
with their handicap as they grow older.
Sickle cell anemia is a physical illness. It
does not affect the mind.
The disease does not affect all Black
people either. It attacks only some offspring of parents carrying the trait. If two
persons with the trait marry, their chi Idren
would have a 25 percent chance of carrying the disease, 50 percent chance of carrying the trait, and 25 percent chance of
being norrnal. That is-one out of four offspring would be born with the disease,
two out of four would have the trait and
one out of four would be born normal.
When either the father or the mother is
afflicted with the disease, all offspring are
born with the trait. When either the mother
or the father carries the trait, the children
have an even chance of being born
normal or with the trait. In most instances
only one parent is trait carrier.
Medical experts say persons carrying
the trait do not usually show physical
defects. In fact, they seldom have knowledge of it unless given a simple blood
test.

http://dh.howard.edu/newdirections/vol1/iss1/5

All carriers of the trait, and victims of
the disease, are born with the condition.
In victims, the disease usually surfaces
about the age of two, requiring costly
medical attention the rest of their lives for
those who live to the median age of 20.
The fatality rate before the median age is
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approximately 50 percent, according to
medical experts.
There is no known cure at the present
time. However,the discovery of antibiotics
has contributed to the easing of pain and
to controlling complications. Meanwhile,
researchers continue to test new drugs.
Doctors say good medical attention, along
with proper home care, can make it possible for those afflicted with the disease
to live comfortably most of the time.
Medical experts in this country trace
sickle cell anemia to Africa, where they
say the trait developed centuries ago as
a bodily defense against certain types
of malaria.
However, a medical scientist from West
Africa told a different story when he
addressed delegates at the symposium
held in Washington. Dr. F. I. D. KonoteyAhulu, a Ghanaian, said sickle cell's
effectiveness as protection against certain types of malaria was for a limited
time only, becoming neutralized when
those born with the malady reached the
ages of two or three. The protection
against malaria did not help adults, he
noted.
Dr. Konotey-Ahulu also explained that
contrary to the general belief of some
people in this country, sickle cell anemia
is by no means an exclusive malady of
Black people. He said its victims include
Europeans who live in the area of the
Mediterranean Sea, particularly Greeks
and Italians.
Disease Identified 63 Years Ago

Sickle cell anemia was first identified
clinically in Chicago in 1910. One of a
handful of significant developments was
achieved in 1949 when a chemist in
California determined that an abnormal
hemoglobin was responsible for the condition. In 1970, a team of doctors in
Michigan announced a promising but still
controversial therapy: Treatment by urea,
an organic waste substance administered
intravenously to halt pain temporari Iy.
However, the drug is still being tested to
determine
effectiveness.
Also under
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test in New York is another recently developed drug called potassium cyanate.
The Future Holds Promise

In many cities across the country, programs to combat the disease have been
developed during the past years. Various
groups consisting of professionals, athletes, artists and lay persons have sprung
up in several places with predominantly
Black populations, such as Washington,
Baltimore, Philadelphia, Pittsburgh, New
York, Detroit and Los Angeles. Their objective: To raise funds or be involved in
some way in a popular cause.
Suddenly, sickle cell anemia is now receiving national attention. The Government is giving it the attention it should
have years ago but did not because, as
Dr. Roland B. Scott says: "It (sickle cell
anemia) occurs in Black people who have
low priority in our culture."
A nationally recognized pioneer in
sickle cell anemia research, Dr. Scott is
Professor of Pediatrics at the Howard
University College of Medicine and Director of the Center for Sickle Cell
Anemia. Using facilities at Howard, Dr.
Scott has done extensive study and research in sickle cell anemia for more than
20 years, often with meager financial
support.
There is no known cure for sickle cell
disease yet, although research efforts are
continuing at various levels. But for research to continue at an intensified pace,
more funds are needed.
The $10 million approved by Congress
has enabled the Department of Health,
Education, and Welfare (HEW) to expand existing programs and create new
ones in the continuing effort to conquer
the disease.
Despite poor response in the past, the
Government is now showing signs of
willingness to support the sickle cell
anemia cause. Its revitalized efforts have
drawn praise as well as criticism. Some
Blacks say the Government is not doing

enough and that more needs to be done.
Other Blacks describe the new thrust by
the Government as a hoax. Still, others
say sickle cell anemia is not a major
health problem of Blacks, nor it is as
deadly as the public is led to believe.
While the debate continues, some positive actions have occurred.
In March 1972, Dr. Rudolph E.Jackson,
a Black physician from Memphis, Tenn.
was appointed by the Secretary of HEW
to head the Government's intensified
program to fight sickle cell disease. Dr.
Jackson is coordinator of the National
Sickle Cell Disease Program under the
National Heart and Lung Institute (NHLI),
a unit of HEW's National Institutes of
Health, (NIH). He also is head of NHLI's
Sickle Cell Disease Branch.
In July 1972, HEW announced the
awarding of grants and contracts worth
$9 million to support 10 comprehensive
Research and community service centers
(including the Center for Sickle Cell
Anemia at Howard); 27 new and 7 existing
collaborative research and development
programs dealing with the nature and
treatment of sickle cell disease, and 19
screening and education clinics in Black
communities for counseling, screening
and definitive diaqnosis of sickle cell
anemia. The largest single HEW grant,
$826,057, went to Dr. Scott and his colleagues at Howard University.
Earlier, the NHLI awarded six contracts
of more than a half-million dollars to
principal researchers at six institutions
(including Meharry Medical College
which received $99,398) to conduct
studies on three forms of promising therapy. One grant of $179,028 went to
Travenol Laboratories, Morton Grove, III.,
which in turn awarded a contract of
$54,000 to Howard University, for the
study of urea, a treatment already in use
on an experimental basis.
In 1971, the Government spent close to
$1 million on sickle cell anemia related
research nationwide. Recipients, as noted
by a spokesman for the HEW, were private and public institutions.
5
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Mary A. Williams, a technician, takes blood
from a young boy by pricking one of his fingers,
a simple and painless process.

These expenditures do not impress
many Blacks. For instance, soon after the
governrnent announced that it had allocated $5 million for sickle cell, Jerry
Fowler, a staff member at a private sickle
cell anemia program in New York, characterized the amount as "a drop in an
empty bucket." Other Blacks charged
tokenism.
Dr. Scott put it this way: "It is a small
amount. We at Howard alone could use
$5 million on research and related services, more space, additional staff, equipment and supplies."
Dr. Scott's views have not changedeven after the Government doubled its
original $5 million expenditures for a nationwide campaign against the disease,
and after almost one-tenth of it was
awarded to Howard.
"When you are talking in terms of the
whole country, $10 million is a very srnall
arnount," he said.
As for the $826,057 awarded to Howard,
Dr. Scott had this to say: "We are grateful,
but our needs have not been satisfied. It
(the money) is going to help. The amount
we got is 45 percent less than what we
applied for. We still need additional
funds."

For instance, during the 15 years prior
to 1972, only $47,000 was received from
the Government by Howard University for
sickle cell anemia research, Dr. Scott
said. Another $54,000 was received indirectly from Travenol for the study of urea.
During the same period, private organizations gave more than a half million
dollars to Howard for sickle cell research,
including a $273,000 grant by the John A.
Hartford Foundation which was awarded
to the College of Medicine for the study of
"Clinical Aspects of Sickle Cell Anemia
in the Newborn and Fetus." Dr. Verle E.
Headings, Associate Professor of Pediatrics and Head of the project, said the
objective is to find effective means for
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Technicians like James Ross test blood samples
determine the presence of sickling traits.
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Nurse Cora Harvey visits a patient to check his
condition.

early diagnosis and treatment of the
disease.
In 1971, Howard University received
$40,000 from the residents of Hartford,
Conn.The money,which was used to open
the Center for Sickle Cell Anemia at
Howard, was raised during a successful
campaign conducted by Leonard J. Patricell i, president of Broadcast-Plaza, Inc.,
WTIC Television Station in that city.
Also, a $100,000 gift was presented to
Howard by Howard L. Sanders, president
of a New York-based advertising and
public relations firm. The $100,000 represented some of the donations received
during a four-hour TV telethon conducted
in New York by Mr. Sander's organization
to raise funds for sickle cell anemia.
However, $50,000 of the money given to
the University is being held in escrow,
pending settlement of a dispute involving
the sponsor of the telethon.
The American Oil Company gave $84,052 to Howard for sickle cell research.
The money was raised from gasoline
sales by 75 cooperating dealers in the
Washington Metropolitan area (with a
matching contribution by the company)
during a 13-week campaign.
The cadets of the United States Military
Academy, who once before donated
$20,000 to Howard's sickle cell effort, a
few months ago gave the University an
additional $11,000 raised during concerts sponsored by the cadets.
By the end of 1972, Howard University's
sickle cell anemia research and educational programs received a total of
$1,497,711.68 from private and Federal
sources.
Research Center at Howard

The Center for Sickle Cell Anemia at
Howard University was founded in 1971
to coordinate Howard's ongoing sickle
cell research and to provide comprehensive screening and genetic counseling
(on voluntary basis) services for students
at the University and people from the
community.
http://dh.howard.edu/newdirections/vol1/iss1/5
According to Dr. Scott and Dr. Robert
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L. Hudson, the Deputy Director, the Center
is a research-training facility for professional and para-professional personnel
whose services are needed to enhance
the fight against sickle cell anemia.
The Center has published several pamphlets on the nature of sickle cell anemia,
for distribution in the community and for
use in public schools. Its diagnostic and
consultation resources- part of the University's medical complex-are open to
the medical community of the District of
Columbia and the surrounding areas.
In June of 1972, the Center's basic
services were extended to include a mobile walk-in clinic in the community,
to provide free screening and genetic
counseling.
As more funds become available, and
as the Center acquires adequate working
space, its services will increase sharply,
Dr. Scott said.
Dr. Marjorie Cates is the Associate Director of the Center. Other Howard doctors
associated with the Center and who have
helped in its development include:
Dr. William H. Bullock, Dr. V. Bhushan
Bhardwaj, Dr. Robert F. Murray Jr., Dr.
Angella D. Ferguson, Dr. Ernest L. Hopkins, Dr. Pongrac N. Jilly, Dr. Calvin C.
Sampson, Dr. Verle E. Headings, Dr. Allen
F. Calvert, Dr. Carlton P.Alexis, Vice President for Health Affairs, and Dr. Marion
Mann, Dean of the College of Medicine.
Dr. Scott is perhaps the leading expert
of a handful of Black scientists who spent
countless hours in laboratories searching
for medication that hopefully will bring
some relief to victims of sickle cell anemia, a disease which until now the rest of
the nation had ignored. (The National
Medical Association and the National Association for the Advancement of Colored
People are among the few early supporters of the sickle cell disease cause.)
Dr. Scott is regarded as dean of the
Black physicians engaged in sickle cell
anemia research. His work began more
than 20 years ago and has won for him
recognition by his colleagues, and a national reputation as -one of the country's

highly regarded authority on sickle cell
disease. He has written more than 50 scientific papers dealing with the clinical
delineation of sickle cell anemia syndromes in infants and children; screened
more than 20,000 persons for the sickle
cell trait; provided genetic counseling
for carriers of the trait, and medical care
for victims of the malady at the University's medical complex.
"What we are doing here is very significant for Black people in this country, the
Caribbean and Africa. It also focuses national and international attention on Howard as a major research center for sickle
cell anemia," Dr. Scott said.
"We need financial assistance from
alumni, Federal and private agencies,
and any legitimate source in order to
properly carry out our mission."
He said sickle cell disease indeed is
one of the major medical problems facing
Blacks, contrary to what other Black
Americans are saying.

23

The National Black Thrust

Elsewhere in the nation, other Black physicians are engaged in research and education like Dr. Scott, but on a smaller
scale. Among them is Dr. Allison B. Henderson of Detroit, Mich., who did his first
research on sickle cell while serving in
the Army in 1945.
Dr. Henderson now conducts most of
the research at his office but, when necessary, uses the facilities of Burton Mercy
Hospital in Detroit.
Another Black physician in the field of
sickle cell research is Dr. Charles F.
Whitten, who has done research for more
than 10 years.
Dr. Whitten also works closely with the
Sickle Cell Detection and Information
Program in Detroit.
In New York, Dr.Yvette F. Frances does
sickle cell research as head of the city's
first Sickle Cell Clinic. Also, she is associated with the Foundation for Research
and Education in Sickle Cell Disease.
The Foundation, according to Jerry
Fowler, a staff member, and a victim of

8
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One of the many functions of the Center for Sickle
Cell Anemia is testing new drugs to be used in
treating patients. Here, a group of representatives
from the Department of Health, Education and
Welfare listens as Dr. William H, Bullock (holding
object) explains urea, a new drug being tested
at the Center.
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The Team- Left to right, V. Bhushan Bhardwaj,
Roland B. Scott, Robert L. Hudson, Pongrac Jilly
and William H. Bullock.
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sickle cell disease, was formed with
donations
received
from private
organizations.
"It is hard to Iive with the disease without proper medical care," Mr. Fowler said
during an interview a few months ago.
Mr. Fowler, 26, received his first treatment when he was nine months old. He
has since been hospitalized more than
125 times, received more than 300 blood
transfusions, with most of the expense
paid by health insurance.
He became associated with the Foundation when it was formed in 1966. Although somewhat similar to the Howard
http://dh.howard.edu/newdirections/vol1/iss1/5
University Center, the Foundation's clini-

cal work is done at five hospitals in New
York City, according to Mr. Fowler.
Other Black Voices

The merits of some sickle cell research
programs and the sincerity of the persons
associated with them especially in the
area of fund-raising, are being questioned
by Blacks.
There have been charges that some individuals associated with sickle cell
anemia programs are interested only in
quick financial gain or publicity.
"There are Blacks and whites in the
community who are only interested in

sickle cell anemia because it is only recently that funds have become available,"
said William Montgomery of Pittsburgh,
Pa., to 1500 delegates attending last
year's annual conference of the National
Association of Black Social Workers in
Nashville, Tenn.
"As funds have become available, numerous people who have never had previous interest in sickle cell have begun to
try to develop various kinds of programs.
As a result, many of them, we feel, are
really in it for their own personal gain
rather than in the interest of providing
some services to people who have sickle
10
cell."
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Elliot Richardson, then Secretary of Health,
Education and Welfare, stopped to chat with a
young sickle cell anemia patient during a visit to
Freedmen's Hospital.
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Still other Blacks, for various reasons,
view the newly-found popularity of sickle
cell as a hoax. They question the motives
of some agencies, including the American
Red Cross, for example, for instituting
sickle cell testing programs.
Professor Naomi Chamberlain, of the
University of Rochester, another delegate
at the social workers conference, noted
how a national organization which previously dealt with hemophiliacs was talking
about the possibility of moving into the
sickle cell field "because they (the organization) can't find enough hemophiliacs."
Some of the critics, among them physicians and psychiatrists, claim the current
popularity of sickle cell is nothing but a
scheme by the establishment to demoralize Blacks; another trick to label Black
victims of the disease genetically deficient creatures.
Dr. Alyce C. Gullattee, psychiatrist at
the College of Medicine at Howard University, has warned Blacks to be aware of
the mass screening for sickle cell trait.
She is convinced the mass screening of
Blacks could be a new means for-eugenic
control.
Likewise, some Blacks have expressed
fear that those with the disease or the trait,
some of them potential parents, may be
counseled not to have children.
However, individuals associated with
sickle cell programs say this won't be
allowed to happen.
Responding to this question, Dr. Jackson, coordinator of the Government's
sickle cell disease program, said:
"This program is not aimed at counseling anyone not to have children. That's
one option they (potential parents) can
have. It is up to the couple."
Marjorie A. Costa, director of HEW's
National Center for Family Planning
Services, said advising victims of sickle
cell not to have children would amount to
"genocide."
"If I hear of any counselors who are in
fact counseling against having children,
I think that would, therefore, be genocide."
Published
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are increasingly calling for more participation in the planning and operation of
both Federal and private sickle cell
anemia programs.
The lack of adequate participation by
Blacks in some programs have in the past
come under fire. One such incident involved several Black employees of NIH,
who staged a protest and forced the Federal health agency to abandon an inhouse sickle cell detection program before it got off the ground. The reason for
dissent: Lack of meaningful input into the
program by Black employees. (Shortly
thereafter, Dr. Jackson was named to head
the national program.)
A Quick Look at Past Years

Times have really changed. Sickle cell
anemia and its victims are now beginning
to get the attention which was lacking
only a few years ago.
Writing in the Journal of the American
Medical Association (October, 1970), Dr.
Robert B. Scott, of the Department of
Medicine, Medical College of Virginia,
noted:
"In 1967 there were an estimated 1,155
new cases of sickle cell anemia; 1,206 of
cystic fibrosis; 813 of muscular dystrophy
and 350 of phenylketonuria (congenital
metabolic defect in infants). Yet volunteer
organizations raised $1.9 million for cystic
fibrosis, $7.9 million for muscular dystrophy, but less than $100,000 for sickle
cell anemia.
"National Institutes of Health grants for
less common hereditary illnesses exceed
those for sickle cell anemia," Dr. Scott
wrote.
Howard University's Dr. Scott wrote
about this neglect in an article published
in the January, 1971 issue of the Journal
of the National Medical Association, an
organization of Black practitioners.
In the article, Dr. Scott made a comparative study between sickle cell disease and other illnesses affecting the
predominantly white population in this
country. He concluded:

"Vast sums of money have been spent
not only from research supported by the
Federal Government but also from popular contributions which support national
organizations interested in diseases such
as muscular dystrophy, special birth defects, hemophilia, etc. On the other hand,
the more commonly occurring sickle cell
disease afflicting mainly the American
Black population has suffered from comparative neglect by the Federal Government and the public at large."
Now, more funds to fight sickle cell
anemia have been promised. Whether
the various research efforts will produce
an effective therapy that will ultimately
end the agony and suffering for victims of
this malady is another question.
-Abdulkadir N. Said-
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